BioInfoBank Library ::
Prevalence of Human Papillomavirus in Women Without Cervical Cancer: A Population-based Study in Eastern India.
Deletions in chromosome 4 differentially associated with the development of cervical cancer: evidence of slit2 as a candidate tumor suppressor gene.
Alterations of ATM and CADM1 in chromosomal 11q22.3-23.2 region are associated with the development of invasive cervical carcinoma.
Frequent alterations of LOH11CR2A, PIG8 and CHEK1 genes at chromosomal 11q24.1-24.2 region in breast carcinoma: Clinical and prognostic implications.
Alterations of RASSF1A in premalignant cervical lesions: Clinical and prognostic significance.
MassARRAY Spectrometry is More Sensitive Than PreTect HPV-Proofer and Consensus PCR for Type-Specific Detection of High-Risk Oncogenic HPV Genotypes in Cervical Cancer.
Genetic and epigenetic changes of HPV16 in cervical cancer differentially regulate E6/E7 expression and associate with disease progression.
Defective dendritic cell generation from monocytes is a potential reason for poor therapeutic efficacy of interferon α2b (IFNα2b) in cervical cancer.
Subtype specific alterations of Wnt signaling pathway in breast cancer: clinical and prognostic significance.
Dysregulated CC receptor/ligand in monocytes/macrophages from tongue squamous cell carcinoma patients is partially rectified by interferon α-2b.
A homeopathic approach to treat patients with advanced gallbladder, periampullary, and liver carcinomas: a report of 3 cases.
Low-risk human papillomavirus type 6 DNA load and integration in cervical samples from women with squamous intraepithelial lesions.
A 7.5-year prospective study of longer than 18 months type-specific human papillomavirus persistence in a routine cytology-based cervical screening population of about 31 000 women in West Germany.
Natural history of persistent high-risk human papillomavirus infections in Korean women.
Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study.
Prevalence and distribution of human papillomavirus types in cervical cancer, squamous intraepithelial lesions, and with no intraepithelial lesions in women from Southern Mexico.
Human papillomavirus infection in women with and without cervical cancer in Nepal.
Human papillomavirus infection in women with and without cervical cancer in Tbilisi, Georgia.
Cervical human papillomavirus infection in Mexican women with systemic lupus erythematosus or rheumatoid arthritis.
Assessing Urine Human Papillomavirus Polymerase Chain Reaction Testing As a Tool for Screening Anal HPV infection in HIV-Positive MSM.
Human Papillomavirus Prevalence and Type Distribution in 3603 HIV-Positive and HIV-Negative Women in the General Population of Tanzania: The PROTECT Study.
|